Long-term Dosing of Intrathecal Baclofen in the Treatment of Spasticity after Acquired Brain Injury

Conclusion Despite the long-term use of ITB therapy in this cohort, the mean daily dose of intrathecal baclofen continued to require adjustments. There was no significant difference in the mean daily dose between patients with a diagnosis of TBI, stroke, or HIE. A complex dosing pattern was used more frequently in patients with stroke.
Source: PMandR - Category: Rehabilitation Source Type: research